• Mon news: Novartis Kisqali breast cancer trial. ESMO news: Bayer, Bristol Myers, Regeneron and more. Biosecure Act fallout. Boston Scientific/Silk Road merger. See more on our front page

Replies
20
Views
1K
Replies
0
Views
1
Replies
535
Views
122K
Replies
158
Views
12K
Replies
10
Views
575
Replies
11
Views
567
  • New replies moderating enabled
Replies
156
Views
10K
Replies
101
Views
6K
Replies
34
Views
3K
Replies
18
Views
2K
Replies
491
Views
76K